Chemicals and Drugs

Bevacizumab

An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

See Also

MeSH Record

Synonyms

4 entry terms
  • Avastin
  • Bevacizumab-awwb
  • Mvasi
  • Bevacizumab awwb

MeSH Record

Aspects Covered

24 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2016 (2002)

MeSH Hierarchy

Tree Numbers

  1. D12.776w.124w.486.485.114w.224w.060w.375w
  2. D12.776w.124w.790.651.114w.224w.060w.438w
  3. D12.776w.377w.715.548.114w.224w.200w.438w

AMA Style

References

  1. National Library of Medicine. Bevacizumab. Medical Subject Headings (MeSH). 2026. Unique ID D000068258. http://id.nlm.nih.gov/mesh/2026/D000068258
  2. Bevacizumab. In: Wikipedia. https://en.wikipedia.org/wiki/Bevacizumab
  3. Bevacizumab. In: Wikidata. https://www.wikidata.org/wiki/Q413299